33 results for «123»

Filter By

33 results

PCI of aged saphenous vein bypass grafts: easy as 1-2-3

11 Oct 2023

High-risk PCI of aged saphenous vein bypass grafts can be made safer by combining the techniques of prophylactic intracoronary vasodilators, distal protection devices, and direct stenting.

Michael P. Savage

Author

Michael P. Savage

Author

Marguerite M. Davis
PCI of aged saphenous vein bypass grafts: easy as 1-2-3

Imaging-guided left main PCI - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

Imaging-guided left main PCI

Transcatheter options for degenerated surgical aortic valves - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Transcatheter options for degenerated surgical aortic valves - LIVE case

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Advanced mitral TEER - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

  • A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Advanced mitral TEER - LIVE case

The importance of IVUS in optimising PCI of the left main coronary artery

03 Mar 2023 – From AfricaPCR 2023

Watch the case of an 89-year-old active male patient with type II diabetes and pulmonary hypertension, awaiting hip replacement, who presented with recently worsening effort dyspnoea, and review his treatment management thanks to the recorded video while following the debate around such intervention.

The importance of IVUS in optimising PCI of the left main coronary artery

Breaking the calcium ceiling in bifurcation stenoses with contemporary PCI

18 May 2023 – From EuroPCR 2023

Watch the case of a 73-year-old man, active smoker, with HTN, dyslipidaemia and a history of severe polyvascular disease, who presented with CCS III angina in the last two months, and find out in this session how he was treated LIVE.

Breaking the calcium

Innovations for the treatment of complex coronary artery lesions from LATAM

21 May 2019 – From EuroPCR 2019

Consult this session on innovations for the treatment of complex coronary artery lesions from Latina America, and learn more about how telemedicine, pre-hospital networking, ambulance communication and procedural refinement impact the results of primary PCI in STEMI patients, how practice and experience influence the results of...

Innovations for the treatment of complex coronary artery lesions from LATAM

Edge-to-edge mitral valve repair : contemporary indications and techniques - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to get updated on current indications and technique of edge-to-edge mitral valve repair.

This session was originally presented during EuroPCR 2021.

Edge-to-edge mitral valve repair : contemporary indications and techniques

"My Take on OCT Trials" by Davide Capodanno: CRT 2024

19 Mar 2024

View a series of commented slides illustrating major takeaways from a network meta-analysis of Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention. These slides and comments were originally shared via Twitter upon the occasion of the 2024 Cardiovascular Research...

Author

Davide Capodanno
'My Take on OCT Trials' by Davide Capodanno at CRT 2024

STS/ACC TVT Registry: Cerebral embolic protection and TAVR outcomes

19 Oct 2020

At TCT Connect 2020, David J. Cohen (Kansas City, Missouri, USA) presented results from an analysis of the TVT registry focusing on impact of Cerebral Embolic Protection (CEP) on TAVR outcomes. Nicolas Dumonteil provides a summary of the key messages.

Author

Nicolas Dumonteil
Live from TCT Connect 2020: The STS/ACC TVT registry

Recurrent common femoral artery stenosis after surgical knot closure: Cut the knot using directional atherectomy

15 Jan 2019

A 70-year-old man without history of peripheral arterial disease presented with severe claudication six months after TAVI which was performed via surgical cut-down common femoral artery access site…

Image in cardiology : Cut the knot using directional atherectomy

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

30 Aug 2022

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Elad Asher

Author

Elad Asher
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

BIOTRONIK Sets New Clinical Benchmark with Ultrathin Strut Orsiro Coronary Drug-Eluting Stent

28 Feb 2022

Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)

07 Nov 2024

Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.

Author

Aaysha Cader
Comparison of puncture success rate between distal radial access and transradial access in patients with STEMI (DRAMI)

Interventional closure of LVOT to LA shunt after aortic valve replacement

30 Jun 2023

Watch the case of a 79-year-old male patient admitted to hospital with progressive dyspnea in NYHA functional class III-IV and signs of fluid overload, who presented a subannular perforation of LVOT in the region of fibrous aortomitral continuity, and find out how he was treated.

Interventional closure of LVOT to LA shunt after aortic valve replacement

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System

15 Feb 2022

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”
Didn’t find what you were looking for?